|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-12-16
|
|
pubmed:abstractText |
Neoadjuvant chemotherapy (NC) is standard therapy for patients with locally advanced breast cancer and is increasingly used for early-stage operable disease. Clinical and pathological responses are important prognostic parameters for NC, which aims to achieve a pathological complete response or tumor reduction to reduce the volume of subsequent breast resection. Clinicopathological markers that predict patient response to NC are needed to individualize treatment.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0364-2313
|
|
pubmed:author |
pubmed-author:Akashi-TanakaSadakoS,
pubmed-author:AndoMasashiM,
pubmed-author:DoiharaHiroyoshiH,
pubmed-author:FujiwaraYasuhiroY,
pubmed-author:HojoTakashiT,
pubmed-author:KatsumataNoriyukiN,
pubmed-author:KinoshitaTakayukiT,
pubmed-author:KohnoTsutomuT,
pubmed-author:MiyakawaKunihisaK,
pubmed-author:SekiKunihikoK,
pubmed-author:ShienTadahikoT,
pubmed-author:ShimizuChikakoC,
pubmed-author:TairaNarutoN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
44-51
|
|
pubmed:meshHeading |
pubmed-meshheading:18953600-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18953600-Breast Neoplasms,
pubmed-meshheading:18953600-Cyclophosphamide,
pubmed-meshheading:18953600-Doxorubicin,
pubmed-meshheading:18953600-Epirubicin,
pubmed-meshheading:18953600-Female,
pubmed-meshheading:18953600-Fluorouracil,
pubmed-meshheading:18953600-Humans,
pubmed-meshheading:18953600-Middle Aged,
pubmed-meshheading:18953600-Multivariate Analysis,
pubmed-meshheading:18953600-Neoadjuvant Therapy,
pubmed-meshheading:18953600-Paclitaxel,
pubmed-meshheading:18953600-Predictive Value of Tests,
pubmed-meshheading:18953600-Remission Induction,
pubmed-meshheading:18953600-Retrospective Studies,
pubmed-meshheading:18953600-Tamoxifen,
pubmed-meshheading:18953600-Tomography, X-Ray Computed,
pubmed-meshheading:18953600-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer.
|
|
pubmed:affiliation |
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan. tshien@md.okayama-u.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
